SiBone $SIBN Shares Acquired by Universal Beteiligungs und Servicegesellschaft mbH

Universal Beteiligungs und Servicegesellschaft mbH increased its holdings in SiBone (NASDAQ:SIBN) by 84.8% in the third quarter, Holdings Channel.com reports. The firm owned 90,028 shares of the company’s stock after purchasing an additional 41,314 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in SiBone were worth $1,325,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. State of Alaska Department of Revenue purchased a new position in SiBone during the third quarter worth about $39,000. Peregrine Capital Management LLC increased its stake in shares of SiBone by 8.4% during the 3rd quarter. Peregrine Capital Management LLC now owns 383,782 shares of the company’s stock valued at $5,649,000 after acquiring an additional 29,670 shares during the last quarter. Assenagon Asset Management S.A. purchased a new position in shares of SiBone during the 3rd quarter worth about $3,297,000. Squarepoint Ops LLC lifted its holdings in shares of SiBone by 61.9% during the 2nd quarter. Squarepoint Ops LLC now owns 60,639 shares of the company’s stock worth $1,141,000 after acquiring an additional 23,174 shares during the period. Finally, State of Wyoming acquired a new stake in shares of SiBone in the second quarter worth approximately $55,000. 98.11% of the stock is currently owned by institutional investors and hedge funds.

SiBone Stock Up 0.2%

Shares of NASDAQ SIBN opened at $16.58 on Friday. The stock has a fifty day moving average price of $18.94 and a 200 day moving average price of $17.01. The company has a current ratio of 7.97, a quick ratio of 6.62 and a debt-to-equity ratio of 0.21. SiBone has a 12-month low of $12.49 and a 12-month high of $21.89. The company has a market cap of $719.41 million, a P/E ratio of -32.51 and a beta of 0.69.

SiBone (NASDAQ:SIBN) last issued its quarterly earnings data on Monday, November 10th. The company reported ($0.11) EPS for the quarter, topping analysts’ consensus estimates of ($0.16) by $0.05. SiBone had a negative return on equity of 12.86% and a negative net margin of 11.24%.The company had revenue of $48.66 million for the quarter, compared to analysts’ expectations of $46.67 million. Research analysts anticipate that SiBone will post -0.78 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on SIBN shares. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of SiBone in a research report on Monday, December 29th. Canaccord Genuity Group boosted their price objective on shares of SiBone from $26.00 to $27.00 and gave the company a “buy” rating in a research note on Wednesday, December 17th. Morgan Stanley upped their price objective on SiBone from $20.00 to $23.00 and gave the stock an “overweight” rating in a report on Tuesday, December 2nd. TD Cowen raised SiBone to a “strong-buy” rating in a research report on Tuesday, January 27th. Finally, Truist Financial boosted their price target on SiBone from $21.00 to $23.00 and gave the company a “buy” rating in a research report on Thursday, December 18th. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $24.33.

Insider Activity

In other news, insider Anthony J. Recupero sold 3,833 shares of the business’s stock in a transaction on Monday, November 17th. The shares were sold at an average price of $17.44, for a total transaction of $66,847.52. Following the transaction, the insider directly owned 268,144 shares of the company’s stock, valued at approximately $4,676,431.36. The trade was a 1.41% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Anshul Maheshwari sold 18,542 shares of the company’s stock in a transaction on Thursday, December 18th. The shares were sold at an average price of $20.15, for a total transaction of $373,621.30. Following the completion of the transaction, the chief financial officer owned 185,231 shares of the company’s stock, valued at $3,732,404.65. This trade represents a 9.10% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 207,886 shares of company stock worth $3,996,367 in the last ninety days. 4.00% of the stock is currently owned by company insiders.

SiBone Profile

Si-BONE, Inc is a commercial‐stage medical device company focused on the design, development and commercialization of implant systems to treat degenerative conditions of the sacroiliac (SI) joint. Its flagship product, the iFuse Implant System, consists of triangular titanium implants that are inserted via a minimally invasive surgical procedure to stabilize the SI joint and alleviate chronic lower back and buttock pain.

FDA‐cleared in 2012, the iFuse portfolio has expanded to include the iFuse-3D and iFuse-3Di devices, which feature a porous, 3D-printed surface to promote bone ongrowth and biological fixation.